RapoportJL. The neurobiology of obsessive-compulsive disorder. JAMA1988; 269: 2888–2890.
2.
InsetTR. New pharmacological approaches to obsessive compulsive disorder. Journal of Clinical Psychiatry1990; 51(Suppl): 47–51.
3.
JuddFKChuaPLynchCNormanT. Fenfluramine augmentation of clomipramine treatment of obsessive-compulsive disorder. Australian and New Zealand Journal of Psychiatry1991; 25: 412–414.
4.
MarkovitzPJStagnoSJCalabreseJR. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder. American Journal of Psychiatry1990; 147: 798–800.
5.
JenikeMABaerLButtolphL. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder. Journal of Clinical Psychiatry1991; 52: 13–14.
6.
EisonASTempleDL. Buspirone: review of its pharmacology and current perspectives on its mechanism of action. American Journal of Medicine1986; 80(3B): 1–9.